microRNA Replacement Therapy
SEC Filings

 
SEC Filings
Date Filed Filing Description View
09-06-16 4 statement, of changes of beneficial ownership HTML PDF XLS Add to Briefcase
09-06-16 3 initial statement of beneficial ownership HTML PDF XLS Add to Briefcase
08-15-16 10-Q quarterly report HTML PDF XLS XBRL Add to Briefcase
08-15-16 8-K current report HTML PDF XLS Add to Briefcase
07-11-16 CT ORDER confidential treatment order HTML PDF
Add to Briefcase
07-06-16 8-K current report HTML PDF XLS Add to Briefcase
06-30-16 8-K current report HTML PDF XLS Add to Briefcase
05-12-16 10-Q quarterly report HTML PDF XLS XBRL Add to Briefcase
05-12-16 8-K current report HTML PDF XLS Add to Briefcase
04-27-16 DEFA14A definitive additional proxy materials HTML PDF
Add to Briefcase
FirstPrevious
3
... NextLast
= add PDF file to Briefcase
© 2017 Mirna Therapeutics, Inc. All Rights Reserved.